Inmune Bio (INMB) Research & Development (2018 - 2025)
Historic Research & Development for Inmune Bio (INMB) over the last 7 years, with Q3 2025 value amounting to $4.9 million.
- Inmune Bio's Research & Development fell 5145.52% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 million, marking a year-over-year decrease of 1928.66%. This contributed to the annual value of $33.2 million for FY2024, which is 6359.69% up from last year.
- Per Inmune Bio's latest filing, its Research & Development stood at $4.9 million for Q3 2025, which was down 5145.52% from $5.8 million recorded in Q2 2025.
- Inmune Bio's Research & Development's 5-year high stood at $10.1 million during Q3 2024, with a 5-year trough of $2.5 million in Q1 2021.
- In the last 5 years, Inmune Bio's Research & Development had a median value of $5.8 million in 2025 and averaged $5.8 million.
- In the last 5 years, Inmune Bio's Research & Development crashed by 5175.44% in 2022 and then skyrocketed by 11033.15% in 2024.
- Quarter analysis of 5 years shows Inmune Bio's Research & Development stood at $7.1 million in 2021, then tumbled by 51.75% to $3.4 million in 2022, then skyrocketed by 76.16% to $6.0 million in 2023, then rose by 22.41% to $7.4 million in 2024, then plummeted by 33.54% to $4.9 million in 2025.
- Its last three reported values are $4.9 million in Q3 2025, $5.8 million for Q2 2025, and $7.6 million during Q1 2025.